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2.1 Introduction
In February 2001, the outline of the human
genome was individually reported by the
International Analysis Team and Celera Genomics.
Now that the genome sequencing of 60 or more
living species have been determined, the so-called
post-genome sequencing studies are getting into
full swing including gene expression analysis,
protein structure analysis, proteome analysis, and
intermolecular interaction analysis. These studies
are intended to efficiently organize and analyze a
vast amount of diverse biological information for
elucidating the biological and medical
implications.To fulfill such a mission successfully,
bioinformatics is essential technology.
In this article, we give an overview of
bioinformatics, focusing on the human genome
studies, and list the challenges in this region.
2.2 Definition of Bioinformatics
Originally, the term "bioinformatics" has been used
to refer to a specific region of study, in which the
viewpoints and philosophy of informatics were
incorporate into bioscience, although the meaning
of it has been steadily extended.
Prof. Toshihisa Takagi of the Institute of Medical
Science,Tokyo University defines bioinformatics as
follows.
"Information technology allows a boundless
searching space (for example, the number
of genes or proteins, or combinations of
interactions between them), which has
required manual examination or
experiments for verification so far, to be
narrowed down and its basic principle"
In the United States, the Biomedical Information
Science Technology Initiative (BISTI) consortium
of the National Institutes of Health (NIH)
differentiates the term "bioinformatics" from the
term "computational biology."
Bioinformatics
Research, development, or application of
computational tools and approaches for
expanding the use of biological, medical,
behavioral or health data, including those to
acquire, store, organize, archive, analyze, or
visualize such data
Computational biology
The development and application of data-
analytical and theoretical methods,
mathematical modeling and computational
simulation techniques to the study of
biological, behavioral, and social systems.
Both of the two terms have almost the same
underlying concept and NIH, perhaps,
differentiates between them to represent
immediate challenges specifically.
This section describes "What is bioinformatics?,"
closely focusing on the concept of bioinformatics
defined by NIH.
2.3 Positioning and
Categorization of
Bioinformatics
2.3.1  Positioning of Bioinformatics
Bioinformatics plays an important role as one of
basic technologies supporting researches in the
life science area, mainly using genome analysis
(Figure 1).
2.3.2  Categorization of Bioinformatics in the
Post-genome Research Area
Table 1 shows the direction of the post-genome
researches, the database of bioinformatics
supporting it, and the data analysis methods. The
post-genome researches have been shifted from
those on the "structure field" into the "relationality
field" and oriented toward researches on cellular
and ontogenetic functions (the "function field")
for the systematic elucidation of life.
In the "structure field", various types of analyses
including the DNA sequences and protein
structure analyses are categorized. Homology
search is one of data analysis methods commonly
used in this field. This method compares DNA
sequences, and extract knowledge of gene
structures, functions from those homologies.
Furthermore, another methods have been
developed, which allows us to estimate the
specific sites of genes based on the statistical
characteristics observed in the gene sequences.
On the other hand, in the "relationality field," the
gene expression analysis, which determines
whether genes are switched on or off, and the
intermolecular interaction analysis, which detects
any interactions among proteins and others, are
categorized. These analyses treat gene
classification based on gene expression
information under various conditions and
intracellular localized site prediction, which
predicts how proteins behave in the cells based
on the physiochemical characteristics of proteins
estimated from amino-acid sequences.
In the "function field", the analysis methods are
grouped and include those for elucidating signal
transmission among the cells and the ontogenetic
mechanism.
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Figure 1: Positioning of bioinformatics in the life science area
Subject Database Data analysis
Structure Sequence, DNA sequences, Homology search,
Structure Gene polymorphism, Gene discovery,
Protein-amino acid Motif extraction,
sequences, Protein structure
Protein structure, etc. Prediction, etc.
Relationality Expression, Gene expression Intracellular localized 
Localization, information, site prediction,
Interaction Intermolecular Intermolecular interaction
interaction, prediction,
Proteome, etc. Gene expression
clustering, etc.
Function Cell function, Signal transmission, Pathway comparison,
Ontogenetic Ontogenetic/ Computer simulation, etc.
function Physiological function,
Immune function,
Brain function, etc.
蛞
蛞
蛞
Source: Authors' compilation based on materials from Prof. Toshihisa Takagi, the Institute of Medical Science, Tokyo University
Table 1: Categorization of bioinformatics in the post-genome research region
Some type of
future strategic
motivation is
critical.
R & D
is
under progress.
In this field, however, few useful data analysis
methods have been developed.
At present, public funds are invested almost
exclusively in researches and developments in the
"structure field", and its infrastructure is being
consolidated. As opposed to this field, almost no
large-scale attempts have been made toward
database arrangement and development of data
analysis methods with respect to the "relationality"
and "function field". This is true, especially, of the
latter field.To facilitate the evolution of these out-
of-stream fields, some type of strategic policy for
motivation must be developed in the near future.
2.4 Current Status of
Bioinformatics
2.4.1  Database
(1) Rapid increase in data amount
The parties concerned are obligated to register
any obtained information on decoded DNA
sequences and others into any of the public
databases of GenBank (U.S.), EMBL (Europe), and
DDBJ (DNA Databank of Japan). These three
databases maintain consistency in data generation
with each other, because they exchange data
among themselves. In recent years, the data
amount has drastically increased as can be seen
from the fact that a vast amount of DNA
sequences were registered, for example, 11.1
billion in January 2001 and 14.1 billion in October
2001, all of which ref lect the recent, rapid
progress in this area, which include registration of
a large number of partial mRNA sequences (EST)
into the databases and un-intermitted elucidation
of the DNA sequences of various species of
organisms (Figure 2).
In data organization, not only base strings are
enumerated but they are also annotated with
various data clarified by analyses, such as the
locations of gene information coding regions as
well as the structures and functions of genes, and
with the literatures related to these genes, all of
which are registered together into the databases.
In the future, it is important to make annotation
attached to sequence data both qualitatively and
quantitatively complete, as sequence data
described here increases.
Additionally, the data structures come into the
complex phase as data on gene expression under
various combinations of conditions and on
intermolecular interaction are added. For this
reason, various requirements constantly would
arise such as further speed-up and increased disk
capacity of information system devices. Besides,
another important challenge to be solved is to
store high quality data in the databases through
researcher's updating of annotation.
(2) Examples of databases
Table 2 shows typical databases commonly used in
the genome research region and others. Generally,
DNAs are easier to be purified than proteins and
their sequences can be determined with less
difficulty using a DNA sequencer, which makes the
database consisting of DNA sequences the largest
of all the databases. In addition to those described
in section (1), the public databases include the
databases containing DNA sequences of human
genes and Single Nucleotide Polymorphisms
(SNPs).
Additionally, there exist various types of databases
containing gene information such as amino-acid
sequences of proteins, motif sequences useful in
predicting gene functions, and protein structures.
It is said that about 400 types of databases can be
found throughout the world.
Note that the journal "Nucleic Acids Research,"
published on January 1 every year, features these
databases.
In Japan, for most of the databases, frequent access
from abroad is not authorized except for some, as
example, the pathway database. For us, Japanese
researchers, to lead the post-genome researches in
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Figure 2: Transition in the number of bases registered in
DDBJ
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Source: Authors' compilation based on DDBJ data
the world, it may be required to build original
databases on a larger scale to deliver gene
information to the countries throughout the
world.
(3) Integration of databases
To successfully perform data analysis using
bioinformatics, combinations of various databases
and searching systems are often used instead of
only one kind of database. For this reason, systems,
which link various databases and searching
systems into one integrated system, have been
developed. Table 3 shows examples of typical
integrated database searching systems.
One problem about database integration to be
solved lies in that no standardization and
coordination have been made for the methods for
displaying database data and for describing
searching conditions. In other words, it is
important that a systematic theory (ontology) be
built using the refined lexis system and describing
method rather than using the concept and
terminology specific to each subject of search.
For example, in the United States, Interoperable
Informatics Infrastructure Consortium (I3C),
which consists of more than 40 biochemical
businesses and information system and/or service
providers such as INCOGEN and Oracle, was
founded in January 2001 and has commenced
activities on propelling standardization efforts for
data exchange, management, and others in the life
science area. At present, I3C is working on the
standardization task of XML data description and
the communications protocol.
2.4.2  Hardware
As described in 2.4.1 (1), in the bioinformatics, it
has been increasingly required that a high level
information system, based on a series of high
performance computers (super computers), be
built to address the rapid increase in data amount.
Table 4 shows the estimation of computer
performance needed for genome analysis.
Assuming some possible evolution in the
technologies for describing and simulating the
complex systems such as the life system, a parallel
computer system with a performance ranging
from several-ten to several-hundred Tera f lops,
18
S C I E N C E  &  T E C H N O L O G Y  T R E N D S
Table 2: Examples of databases
Content in database Database name (country) Content in database Database name (country)
DNA sequences GenBank (U.S.) Amino-acid sequences SWISS-PROT (Europe)
EMBL (Europe) PIR (U.S.)
DDBJ (Japan)
DNA sequences of UniGene (U.S.) Amino-acid sequence Pfam (Europe)
human genes domains
Single Nucleotide dbSNP (U.S.) Amino-acid motifs PROSITE (Europe)
Polymorphisms JSNP (Japan) BLOCKS (U.S.)
Genetic diseases OMIM (U.S.) Protein structures PDB (U.S.), SCOP (Europe)
Mutation Database (Europe) CATH (Europe)
General human sequence HGREP (Japan) Pathways KEGG/PATHWAY (Japan)
informations Ensembl (Europe)
General human LocusLink/Refseq (U.S.) Literatures MEDLINE (U.S.)
informations GDB (Canada)
Table 3: Examples of typical database searching
systems
Integrated system Service provided from
DBGET (Japan) Institute for Chemical Research,
Kyoto Univ., 
Institute of Medical Science,
The Univ. of Tokyo
Entrez (U.S.) National Center for Biotechnology
Information (NCBI)
SRS (Europe) European Molecular Biology
Laboratory (EMBL)
Table 4: Computer performance needed for major
genome analyses
Source: Authors' compilation by making reference to the
materials provided by Professor Nishikawa based on
the data of the 2000 Report "Advanced Computational
Structural Genomics", U.S. DOE Scientific Simulation
Initiative (SSI)
Genome analysis Performance (flops)
Protein family classification 1 Tera
Phylogenetic diagram 10 Tera
Sequence assembly 102 Tera
Sequence comparison >102 Tera
Gene modeling 105 Tera
which consists of several thousands or even
several-ten thousands of processors, may be
required ("Strategy for Genome Information
Science in Japan"—the Genome Science
Committee, Life Science Working Group, Council
for Science and Technology Policy, November
2000).
For example, ASCI white, which was ranked first
out of the "TOP 500 worldwide high-performance
computers" announced in November 2001, has
12.3 Tera flops of peak performance.
In the bioinformatics, parallel processing systems
and parallel computers are under development.
On the other hand, software development lags
behind, for example, delays due to difficulties in
integrating applications running on high-
performance computers into the parallel system.
(Note: f lops is a measure of calculation
performance indicating the speed a computer can
calculate floating-point calculations.Tera=1012)
2.4.3  Data Analysis Methods and Software
Table 5 lists the data analysis methods for
identifying the desired knowledge from databases
and software executing these methods.
2.4.4  Industrialization of Bioinformatics
In recent years, bio-related venture businesses
have proactively developed their activities
centering around developed countries in the
world; as of 2000, about 160 in Japan, about 1,300
in U.S., and about 700 in Europe.
In the bioinformatics, such bioinformatic
businesses actively participate in this industry
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Table 5: Main data analysis methods and software
Method Descriptions of analyses and example software
Homology search Compares among sequences to extract knowledge based on their homology and is most
commonly used. BLAST, FASTA, and Smith-Waterman, as well as high-sensitive
programs, which can extract even weak homology, such as PSI-BLAST, SAMT99.
Gene discovery Estimates genes based on statistical characteristics observed in gene sequences and is
used to extract unknown genes, which cannot be discovered by homology search. 
GENSCAN and DIGIT.
Motif extraction Identifies characteristically short sequences (motif), which are found in DNA binding sites
and functional sites such as an oxygen active center. Compares sequences against the
databases containing motifs of amino-acid sequences, such as PROSITE.
Intracellular localized Based on hydrophobicity indexes of amino acids, physicochemical properties of electric
site prediction charges, and the sequences of localized signals, etc., predicts where biosynthesized
proteins go within cells. Signal P, which predicts the positions of signal sequences,
PSORT, which predicts localized positions, and SOSUI and TMHMM, which predict
membrane-penetrating regions.
Protein structure Swiss-Model and MODELLER homology modeling software, which predict protein
prediction structures based on homology among sequences. DALI and MODBASE, which
determine similarities based on the results of comparison among protein structures.
Source: Authors' compilation by referencing the "Genomic Medical Science and Introduction to Bioinformatics",
Experimental Medicine Vol. 19, No. 11 (extra number) P. 61-66, P. 73-81
Table 6: Main bioinformatics-related venture businesses in the United States and Europe
Company Business
Incyte Genomics (U.S.) cDNA database, gene expression (DNA chips), etc.
Human Genome Sciences (U.S.) Secretory protein database, membrane protein database, gene drug
development, etc.
Celera Genomics (U.S.) Genome database (human, mouse, and Drosophila), proteome, SNP, etc.
Gene Logic (U.S.) Gene expression database, etc.
CuraGen (U.S.) Gene expression database, SNP database, etc.
Genset (France) Disease analysis using SNP database, etc.
deCODE genetics (Iceland) Clinical database, genealogy database, polymorphism database, etc. 
Source: Authors' compilation by making reference to the materials provided by Professor Nishikawa based on the
"Genome Information Ventures (P. 96-102), Leading Edge of Genome Medical Science and Worldwide Bio-
Ventures, Yodosha, 2001
such as those providing the databases and
software, which are customized for user
requirements. To successfully perform research
and development using genome information, any
data management system and search assistance
system, which can satisfy the requirements
including higher security, faster analysis, and
adaptation to individual researches, are essential in
addition to public databases and software
commonly available. Table 6 shows main
bioinformatics-related venture businesses in the
United States and Europe.
2.5 Activities for
Propelling Bioinformatics
2.5.1  Political Principle
Recently, political emphasis has been laid on
bioinformatics in many countries throughout the
world, assuming that it is critical to propel
researches on genome. Table 7 shows the main
propelling bases for bioinformatics in the United
States and Japan. Besides, active measures are
conducted mainly in the laboratories of
universities.
In Japan, bioinformatics was listed as one of the
challenges to be exclusively and strategically
tackled in the life science area in the 2nd-stage
Science and Technology Basic Plan (decided by
the Government of Japan, March 2001). In
addition, it was listed as one of the emphasized
issues in the "2001 Emphasized Guideline on
Advancement of Science and Technology" (Policy
Committee, Council for Science and Technology
Policy, June 2000), with 10.4 billion yen budgeted
for 2001. In 2002, the Ministry of Education,
Culture, Sports, Science and Technology founded
the Institute for Bioinformatics Research and
Development (Chiyoda-ku,Tokyo) and the Ministry
of Economy,Trade and Industry formed the Japan
Biological Information Research Centre (Kohto-ku,
Tokyo) and the Computational Biology Research
Center (Kohto-ku, Tokyo), respectively. The Japan
Biological Informatics Consortium (JBiC),
consisting of 87 businesses in the private sector, is
making great efforts in bioinformatics research
and development.
In the United States, from an early stage,
bioinformatics actively advanced under the
leadership of NIH. NLM, which has jurisdiction
over NCBI, playing a core role in bioinformatics in
the United States, was budgeted about 246 million
dollars (about 29 billion yen) for 2001.
In addition, in 2001, the Center for Bioinformatics
and Computational Biology (CBCB) was founded
as an organization, which fosters bioinformatics
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Table 7: Main bases for propelling bioinformatics in Japan and the U.S.
Japan Ministry of Education, Center for Information Biology and DNA Data Bank of Japan, National Institute of Genetics
Culture, Sports, Human Genome Center, Institute of Medical Science, Tokyo Univ. 
Science and Technology Bioinformatics Center, Institute for Chemical Research, Kyoto Univ.
Genomic Sciences Center, Institute of Physical and Chemical Research (RIKEN)
Institute for Bioinformatics Research and Development, Japan Science and Technology
Corporation(JST)
Ministry of Economy, Computational Biology Research Center (CBRC), National Institute of Advanced Industrial 
Trade and Industry Science and Technology(AIST)
Japan Biological Information Research Centre (JBIRC), National Institute of Advanced
Industrial Science and Technology (AIST)
Japan Biological Informatics (JBiC), etc.
U.S. Department of Health and Human Services (DHHS)
National Institutes of Health (NIH)
National Library of Medicine (NLM)
National Center for Biotechnology Information (NCBI)
National Institute of Biomedical Imaging and Bioengineering(NIBIB)
National Institute of General Medical Sciences (NIGMS)
Center for Bioinformatics and Computational Biology (CBCB)
National Human Genome Research Institute (NHGRI)
Biomedical Information Science and Technology (BISTI) Consortium
Department of Energy (DOE)
Office of Biological and Environmental Research (BER)
National Science Foundation (NSF), etc.
researches, and will subsidize about 10 million
dollars (about 1.2 billion yen) to universities and
other institutes during its the initial year.
Furthermore, DOE, NSF, DARPA(Defense Advanced
Research Projects Agency) and others propel
researches in the bioinformatics area.
In Europe, EMBL(European Molecular Biology
Laboratory) and EBI(European Bioinformatics
Institute ; one of the divisions of EMBL) as well as
Sanger Center (U.K.) are playing core roles in
developing bioinformatics. The public
bioinformatics budget of Europe for 2000 is 100
million Euro dollars (about 10 billion yen), among
which 10 million Euro dollars is allocated to EBI.
2.5.2  Activities for Training 
With respect to recent researches in the life
science area, the quality and performance of
bioinformatics tools to be used and techniques for
making full use of them are the main factors
contributing to the progress of research and
development. For this reason, the need for talents
who can use these sophisticatedly tools and
people who can develop superior algorithms and
software, has rapidly increased. However, since this
bioinformatics is a new study, a sufficient amount
of personnel has not been trained and training has
become a major problem to be solved in many
countries.
"Strategy of Genome Information Science in Japan"
(November 2000, Genome Science Committee,
Life Science Working Group, Council for Science
and Technology Policy) defines the tentative
requirements for training as follows.
1) Training of adaptable talents: Development of
education and training programs to make full
use of existing talents, as well as provision of
training opportunities and incentives.
2) Training near-future and future talents:
Formation of bases for giving places where
communication of research information and
experiment of test and fault is achieved by
reorganizing graduate school courses and
major subjects of universities.
With respect to requirement 1), for example,
Institute for Bioinformatics Research and
Development, Japan Science and Technology
Corporation(JST), commenced the "Genome
Literacy Course," a practical training program, in
cooperation with the Human Genome Center,
Institute of Medical Science, Tokyo University, in
2001. In this course, a training program is
provided for researchers to learn the methods of
using databases and analytical software.
With respect to requirement 2), a new business for
training was started in 2001 ,by allocating the
2001 Special Coordination Funds for Promoting
Science and Technology (SCF), and four themes
were adopted. For example, Keio University's
"System biologist education and training program"
was initiated, in which a new life information
course will be established in the Department of
Science and Engineering.This program is intended
to help students learn about experiments and
computer science as one method for
understanding biology based on chemistry,
physics/information, and mathematics. This
program has as its target that about 40 graduated
students and about 25 masters will be provided to
pharmaceutical and computer companies and
consulting firms.
In the United States, the subject of training is
actively attacked as well. The divisions of NIH
include the Fogarty International Center (FIC), the
National Cancer Institute (NCI), the National
Institute of Aging (NIA), the National Institute of
General Medical Sciences (NIGMS), the National
library of Medicine (NLM), and the National
Human Genome Research Institute (NHGRI). Out
of them, for example, NLM invested funds in 12
training programs such as those in Yale University
and Columbia University.
2.6 Conclusion
Bioinformatics can be viewed as not only a basic
technology supporting the researches in the life
science area but also as a new region bearing the
life science aera, a fused interdisciplinary area.
At present, to analyze DNA sequences and protein
structures, databases and data analysis methods are
being reorganized. In the future, research and
development of databases and data analysis
methods needed for researches on cell functions
and ontogenetic functions must be strategically
advanced.
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Since databases are the foundation for data
analysis, it is necessary to always attain high
quality data. It is important that appropriate data
management, such as update of annotation data, is
maintained.
With respect to hardware, even the current
highest-performance computers are insufficient
for various types of genome analyses, and further
improvement of performance is required. Similarly,
software must be improved so that applications
running on high-performance computers can be
integrated into one parallel system.
In Japan, efforts in forming the bases for
propelling bioinformatics and in developing and
implementing programs for training have just
started. Considering the importance of
bioinformatics in the future life science area, it is
desirable that further continuous policies are
implemented.
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